WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 112 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $14,756,000 | +2.2% | 341,500 | 0.0% | 0.07% | +17.5% |
| Q2 2015 | $14,432,000 | +9.0% | 341,500 | 0.0% | 0.06% | +11.8% |
| Q1 2015 | $13,243,000 | +56.4% | 341,500 | +35.8% | 0.05% | +50.0% |
| Q4 2014 | $8,468,000 | +20.0% | 251,500 | +24.8% | 0.03% | +17.2% |
| Q3 2014 | $7,057,000 | +6.6% | 201,500 | 0.0% | 0.03% | +11.5% |
| Q2 2014 | $6,621,000 | -14.7% | 201,500 | -4.3% | 0.03% | -18.8% |
| Q1 2014 | $7,759,000 | +20.9% | 210,500 | +25.9% | 0.03% | +18.5% |
| Q4 2013 | $6,417,000 | +1277.0% | 167,200 | +883.5% | 0.03% | +1250.0% |
| Q3 2013 | $466,000 | +0.9% | 17,000 | -22.7% | 0.00% | +100.0% |
| Q2 2013 | $462,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coupland Cardiff Asset Management LLP | 448,361 | $15,096,000 | 21.12% |
| Sloane Robinson LLP | 107,400 | $3,616,000 | 6.28% |
| Sensato Investors LLC | 327,754 | $11,035,000 | 3.26% |
| Grandeur Peak Global Advisors, LLC | 388,810 | $13,091,000 | 2.94% |
| GRATRY & Co LLC | 205,800 | $7,899,000 | 2.59% |
| THOMAS WHITE INTERNATIONAL LTD | 464,926 | $15,654,000 | 2.15% |
| COMGEST GLOBAL INVESTORS S.A.S. | 1,819,980 | $61,279,000 | 1.87% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,169,686 | $39,383,000 | 1.64% |
| Ninety One North America, Inc. | 133,372 | $4,491,000 | 1.32% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 87,560 | $2,948,000 | 1.27% |